Bill Snyder Archive — Page 112 of 119
-
February 14, 2013
Harvard’s Kahn set for Discovery Lecture
C. Ronald Kahn, M.D., renowned for his contributions to the field of insulin signaling and its role in type 2 diabetes and obesity, will deliver the next Flexner Discovery Lecture on Thursday, Feb. 21. -
February 11, 2013
VU, GlaxoSmithKline team to develop novel treatments for severe obesity
Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity. -
February 7, 2013
Humble yeast helps predict how genes are regulated
Budding yeast occupies a place of honor in the pantheon of human history. Saccharomyces cerevisiae has been used for baking and alcoholic fermentation for thousands of years. -
February 7, 2013
For people with ASD, adulthood no easy transition
One of the critical, unmet needs for people with autism spectrum disorder (ASD) is support for the transition into adulthood. -
January 31, 2013
Vanderbilt, GE unite to study colon tumor development
Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop. -
January 31, 2013
ResearchMatch adds registry for autism disorders
ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies.